caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1750306577

Eugenio MonasterioM.D.

Physical Medicine and RehabilitationRichmond, VAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where Eugenio Monasterio's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
VIRGINIA COMMONWEALTH UNIVERSITY HEALTH SYSTEM AUTHORITY2767
VIRGINIA COMMONWEALTH UNIVERSITY HEALTH SYSTEM AUTHORITY2469
William Carter
Physical Medicine and Rehabilitation · Richmond, VA
23124
James Mcgowan
Physical Medicine and Rehabilitation · Richmond, VA
17236
Richard Kunz
Physical Medicine and Rehabilitation · Richmond, VA
16229
William Walker
Physical Medicine and Rehabilitation · Richmond, VA
1481
Lester Fahrner
Diagnostic Radiology · Roseville, MN
1247
Warren Stringer
Diagnostic Radiology · Richmond, VA
1141
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
87
Beneficiaries
—
Total drug cost
$7K
Distinct drugs
6
Brand share
0.0%
Top prescribed drugs
Baclofen26 claims
Divalproex Sodium13 claims
Famotidine12 claims
Omeprazole12 claims
Pantoprazole Sodium12 claims
QUALITY · MIPS · 2024
Final MIPS score
84.0
Quality
69.9
Cost
77.4
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.38%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.